RTX vs UNH: Which Is the Better Buy?
Side-by-side comparison of RTX Corporation and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
RTX Corporation · Industrials
$185.60
-25.2% upside to fair value
Grade D
VS
UnitedHealth Group Incorporated · Healthcare
$400.96
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+45.0%).
UNH trades at a lower forward P/E
(30.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
RTX |
UNH |
| Current Price |
$185.60 |
$400.96 |
| Fair Value Estimate |
$138.81 |
$581.39 |
| Upside to Fair Value |
-25.2%
|
+45.0%
|
| Market Cap |
$249.9B |
$364.1B |
| Forward P/E |
34.3x
|
30.2x
|
| EV / EBITDA |
18.3x
|
18.0x
|
| Price / Sales |
2.8x
|
0.8x
|
| Price / FCF |
29.9x
|
18.5x
|
| Revenue Growth YoY |
+8.7%
|
+2.0%
|
| Gross Margin |
20.2%
|
18.8%
|
| Operating Margin |
10.9%
|
4.2%
|
| Return on Equity |
11.2%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.34%
|
5.4%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
RTX Corporation is a leading aerospace and defense company with a strong competitive moat driven by scale and an installed base in commercial aerospace via Pratt & Whitney and Collins Aerospace, and defense through Raytheon. The company benefits from a large multi-year backlog of approximately $270 billion supporting steady cash flow and mid-single-digit organic growth. Despite solid revenue grow…
UnitedHealth Group Incorporated operates as a diversified healthcare company with leading positions in healthcare plans through UnitedHealthcare and health services via Optum. The business quality is high due to its durable competitive advantages including scale, integration of Optum and UnitedHealthcare, strong data and distribution infrastructure, and incumbency in Medicare Advantage and care d…
Accumulation Zones
| Metric |
RTX |
UNH |
| Zone Low |
$104.11 |
$436.04 |
| Zone High |
$117.99 |
$494.18 |
| In Buy Zone? |
No
|
Yes
|